Printer Friendly

SCRIPT SYSTEMS, INC. SIGNS AGREEMENT WITH WARNER-LAMBERT

 PRINCETON, N.J., May 18 /PRNewswire/ -- Script Systems, Inc. (NASDAQ: SCPT), announced today the execution of an agreement with Warner-Lambert Company, the international healthcare and consumer products organization. Under the agreement, Warner-Lambert will license the Script System software for its occupational medicine clinics.
 Frederick Neufield, chief operating officer of Script Systems, Inc., said, "Occupational medicine clinics represent a key market for Script. We have invested and will continue to invest heavily in products for these facilities. The Warner-Lambert agreement is an important building block for Script."
 Under the Warner-Lambert agreement, Script will provide the Clinical Management software including its occupational medicine module. Script has also agreed to develop additional features for Warner-Lambert.
 Script Systems is a leading provider of management information systems for physicians' offices, clinics and pharmacies. The company is headquartered in Princeton.
 -0- 5/18/93
 /CONTACT: Sam Witchel of Scharff, Witchel & Co., Inc., 212-983-1060, for Script Systems, or Barrett C. O'Donnell of Script Systems, Inc., 609-987-8635/
 (SCPT)


CO: Script Systems, Inc.; Warner-Lambert Company ST: New Jersey IN: SU: LIC

TS-WB -- NY088 -- 9837 05/18/93 13:59 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 18, 1993
Words:181
Previous Article:JAY LENO TO HOST HARLEY-DAVIDSON 90TH ANNIVERSARY REUNION
Next Article:NAB ASSET CORPORATION ANNOUNCES FIRST QUARTER 1993 RESULTS
Topics:


Related Articles
COLUMBIA LABORATORIES SIGNS LETTER OF INTENT TO LICENSE AND SUPPLY REPLENS AND OTHER WOMEN'S OTC HEALTH CARE PRODUCTS
WARNER-LAMBERT COMPANY TO MARKET COLUMBIA LABORATORIES' REPLENS: AGREEMENT SIGNED FOR LICENSE AND SUPPLY ARRANGEMENT
CELESTIAL SEASONINGS AND WARNER-LAMBERT CO. SIGN LETTER OF INTENT TO PRODUCE SPECIALTY HERBAL PRODUCTS
CELESTIAL SEASONINGS AND WARNER-LAMBERT SIGN LICENSE AGREEMENT FOR CELESTIAL SEASONINGS SOOTHERS HERBAL THROAT DROPS
Warner-Lambert Adopts Consilium(R) FlowStream(R) MES as Corporate Standard for Manufacturing Execution Systems
Parke-Davis Signs Multi-Year Agreement with Tripos for Expanded Access to Discovery Software
Simulations-Plus Announces Parke-Davis Signs Agreement To Beta Test GastroPlus(TM) Software
Aurora Biosciences Announces Completion Of First Stage of UHTSS for Warner-Lambert.
Onyx and Warner-Lambert to Jointly Develop Anticancer Virus Products.
Onyx Pharmaceuticals Reports 1999 Financial Results and Equity Investment.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters